February 23, 2021 coronavirus news | CNN

February 23 coronavirus news

mose family
Couple shares warning sign linked to Covid-19 after daughter's death
05:56 - Source: CNN

What you need to know

  • The US has passed half a million Covid-19 deaths, even as new cases are falling sharply across the country and the vaccine effort cranks up.
  • Covid-19 is likely to be a problem for the next few winters, despite vaccination programs, England’s chief medical officer said.
  • China responded to CNN’s exclusive report on how a WHO panel will recommend “deeper” study of early Covid-19 clues, saying that Chinese experts conducted “lots of virus tracing work.”

Our live coverage has ended. Follow the latest on the coronavirus pandemic here.

42 Posts

More than 1,900 cases of concerning variants reported in the US, CDC says

At least 1,932 cases of coronavirus strains first spotted in the UK, South Africa and Brazil have been reported in the United States, according to data updated Tuesday by the US Centers for Disease Control and Prevention.

The vast majority of these cases, 1,881, are the more contagious variant known as B.1.1.7, which was originally detected in the UK. This variant has been found in 43 states, Puerto Rico and Washington, DC. More than a quarter are in Florida.

In addition, there are 46 total cases of a strain initially seen in South Africa, called B.1.351, in 13 states and Washington, DC.

Lastly, five total cases of the P.1 strain first linked to Brazil have been discovered among four states.

CDC says this does not represent the total number of such cases circulating in the US, but rather just those that have been found by analyzing positive samples. The agency cautions that its numbers may not immediately match those of state and local health departments.

Colombia authorizes AstraZeneca vaccine

Colombia has authorized the Oxford/AstraZeneca vaccine for emergency use, the director of local medical authority INVIMA, Julio Cesar Aldana, announced Tuesday. 

Speaking on television as part of President Ivan Duque’s daily address to the nation, Aldana said that the country expects to receive the first AstraZeneca doses through the COVAX mechanism in coming weeks.

This is the third vaccine authorized by Colombia after the Pfizer/BioNTech vaccine and China’s SinoVac.

Colombia started vaccinations on Feb. 17.

GOP senator pushes CDC to issue clear guidance for vaccinated Americans, particularly for seniors

Republican Sen. James Lankford is urging the US Centers for Disease Control and Prevention to immediately issue guidance for vaccinated Americans, saying it’s “obviously, one of the top questions” for the more than 40 million people who have received at least one dose of the Covid vaccine, and particularly crucial for vaccinated seniors who have “endured more isolation than any other population” during the pandemic.

“We’ve got 42 million Americans that have been vaccinated at this point that are all asking the same questions” about safely reengaging with family members, going to the store, among other activities, but they’re waiting for clarity from US health officials, Lankford said.

Earlier this month, the Oklahoma Republican wrote a letter to CDC Director Dr. Rochelle Walensky, asking the agency to proactively release recommendations for fully vaccinated Americans. 

Lankford said he has not heard back from the CDC, but is currently trying to set up a call to discuss it with them.

Meanwhile, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has reiterated in recent days that there will be new firm recommendations coming out very soon. 

UK variant likely to drive new wave of US transmission in spring, experts say

A new, more contagious variant of coronavirus first seen in the UK is likely to fuel a surge of cases in the US in spring, several experts predicted Tuesday. They say the best way to get out ahead of it is to vaccinate as many people as possible.

The variant called B.1.1.7 was suspected of causing renewed spread in Britain and it’s been seen across much of the US – more than 1,880 cases in 45 states, according to the US Centers for Disease Control and Prevention. But those are only the cases detected by sequencing, which falls short in the US, said virus expert Trevor Bedford of the University of Washington and the Fred Hutchinson Cancer Research Center.

Vaccination efforts and mitigation efforts such as mask use and continued social distancing will help bring spread under control, Bedford said, adding, it’s possible, a new surge could begin in the fall.

Dr. Josh Schiffer, an infectious diseases specialist at Fred Hutch who has been modeling patterns of spread, agreed. “I think with the newly infectious variants, I think it is going to be difficult to prevent a fourth wave altogether,” Schiffer said. 

Vaccination will be the best way to slow any renewed surges, the experts said. “We do want a lot of vaccines and strong robust immunity from those vaccines,” Bedford said.

Dr. Larry Corey, a University of Washington vaccine expert who has been leading clinical trials of coronavirus vaccines, said the vaccines available so far appear to protect people from the variants. “The great thing to remember is that the vaccines appear to induce better immunity than natural infection. This is a major achievement,” Corey said.

Report calls for delaying second doses of vaccine, warns of surge fueled by coronavirus variant

A new report out Tuesday warns that a more transmissible variant of coronavirus threatens to start a renewed surge of infections in March, and suggests the US speed up vaccination by skipping second doses for now.

People over 65 should go to the front of the line, since they are by far the most vulnerable to severe disease and death, Epidemiologist Michael Osterholm and colleagues at the Center for Infectious Disease Research and Policy at the University of Minnesota recommended.

They call on the US Food and Drug Administration and the US Centers for Disease Control and Prevention to quickly assemble advisers to help change vaccination guidelines to get more vulnerable people vaccinated more quickly, before the B.1.1.7 variant of the virus, first seen in the UK, causes more spread.

“If the US experiences a surge similar to that seen in the UK, one could expect to see unprecedented healthcare demand of 175,000 to 193,000 hospitalizations per day — far surpassing the US peak of 132,474 individuals hospitalized with COVID-19 set in early January,” the report reads. Right now, just over 55,000 people are currently hospitalized for Covid-19 in the US, according to the Covid Tracking Project.

So far, according to the Centers for Disease Control and Prevention, about 44.5 million people have received at least one dose of coronavirus vaccine and just under 20 million have gotten both doses.

Both the Pfizer and Moderna vaccines are meant to be given as two doses, three or four weeks apart, but the report recommends delaying that second dose to get more people at least partial protection.

“There is a narrow and rapidly closing window of opportunity to more effectively use vaccines and potentially prevent thousands of severe cases, hospitalizations, and deaths in the next weeks and months,” it reads.

It also says the FDA should consider authorizing a half-dose of Moderna’s vaccine, based on evidence that even half a dose provides good protection, at least at first.

New studies raise concerns about coronavirus variant seen in California

Two studies due to come out soon raise concerns about a new coronavirus variant that scientists have been keeping an eye on in California.  

They hint that the variant might not only be more contagious, but may cause more severe disease, as well. The research is in its very early stages, has not been published or peer reviewed, and needs more work, the researchers stressed.

A team at the University of California, San Francisco, tested virus samples from recent outbreaks across California and found it was becoming far more common. It wasn’t seen in any samples from September but by the end of January it was found in half the samples. 

This variant, which the team calls B.1.427/B.1.429, has a different pattern of mutations than the variants first seen in the UK, called B.1.1.7 and in South Africa, called B.1.351. One mutation, called L452R, affects the spike protein of the virus, which is the bit that attaches to cells the virus infects.

And they found some evidence it is more dangerous.

“In this study, we observed increased severity of disease associated with B.1.427/B.1.429 infection, including increased risk of high oxygen requirement,” they wrote in their report, which is to post to a preprint server later this week after public health officials in San Francisco review it.

Chiu said it should be designated a variant of concern and should be made a priority for study.

A second team at Unidos en Salud, a San Francisco-based nonprofit offering fast testing in San Francisco’s Mission District, tested 8,846 people over the month of January and sequenced the virus from 630 of the samples. They also found a rapid increase in the variant.

“The research findings indicate that the L452R variant represents 53% of the positive test samples collected between January 10th and the 27th. That is a significant increase from November when our sequencing indicated that this variant comprised only 16% of the positive tests,” Dr. Diane Havlir, an infectious diseases expert at UCSF who is helping lead the study, said in a statement.

Havlir’s team is also preparing their findings for publication.

Republicans begin new push against Biden's Covid-19 relief plan 

Sen. John Thune speaks during a news conference in the U.S. Capitol on Tuesday, February 23.

Republican leaders in both chambers are maneuvering to keep all of their members in line against the $1.9 trillion Covid-19 relief plan, a move that would deny President Biden a bipartisan victory and one that could scuttle the bill in the Senate if any Democrat breaks ranks. 

But the move amounts to a political risk for Republicans with polls showing clear majorities of Americans supporting an emergency rescue package and with the economy still reeling from the coronavirus pandemic.  

So Republicans now plan to begin an urgent public relations push to argue that the bill is bloated, poorly targeted and contains a hodge-podge of measures aimed at pleasing the Democratic base – a message that party leaders discussed with their members at a private GOP lunch on Tuesday and that they plan to echo in the days ahead, attendees say. 

At the lunch on Tuesday, GOP senators talked at length about the Democrats’ bill, with attendees emerging criticizing it in sharp terms. They discussed their strategy for putting Democrats in a difficult political spot when amendment votes happen next week in the Senate, while also putting forward some middle-of-the-road amendments that could attract some Democratic support, according to attendees. 

And afterward, Senate Minority Leader Mitch McConnell blasted the Democrats’ plan as “totally partisan,” while acknowledging that his party had work to do on its messaging in the face of public support for the Biden plan.  

“I’m sure everybody would love to get a check,” McConnell said, referring to the checks of up to $1,400 for certain individuals in the proposal. “But they haven’t yet learned about what else is in it and part of our job as the substantial minority, remember we’re in a 50-50 Senate here, is to make sure the American people fully understand what’s being proposed.”

Democrats, however, argue that they have a mandate after winning the White House and the Senate and are taking urgently needed action to deliver aid to an American public suffering under the devastating toll of the ongoing pandemic. They have insisted they are willing to work with Republicans but will not water down the plan — a lesson they say they learned from then-President Barack Obama’s first stimulus plan in 2009.  

CNN’s Olanma Mang, Ted Barrett and Lauren Fox contributed reporting to this post.

White House says 2 million doses of J&J vaccine should be ready next week, pending authorization

A  dose of the Johnson & Johnson COVID-19 vaccine is prepared for a clinical trial on December 15, 2020 in Aurora, Colorado.

President Biden’s coronavirus advisers told governors today that they believe an estimated two million doses of the Johnson & Johnson vaccine will be available next week pending emergency use authorization, according to a source familiar with the conversation. 

A White House official confirmed the conversation and said, “If an EUA is issued, we anticipate jurisdictions will get an allocation of around 2 million doses of J&J supply next week.”

Richard Nettles, a Johnson & Johnson executive, told a House panel earlier Tuesday that they expect to ship nearly four million doses upon authorization. It’s not clear why the numbers are different.

The Johnson & Johnson vaccine was designed to be a one dose shot, as opposed to the two doses required for the Pfizer and Moderna vaccines. 

Biden indicates masks will be sent directly to Americans

President Biden indicated the White House will move to send masks directly to the American people as the country continues to grapple with the coronavirus pandemic, something that was originally proposed by health officials during the Trump administration but blocked by the former President.

“We could have saved literally an awful lot of lives if people had listened. We turned wearing masks into a political statement. If you were for this thing, you wore it, if we were for somebody else, you didn’t wear it, when in fact, it’s just plain basic science,” Biden said.

Earlier this month, White House chief of staff Ron Klain said that the Biden administration is hoping to resurrect a proposal from the Trump administration send masks directly to Americans.

“This was an idea that really came up last year in the Trump administration — the public health agencies recommended it, President Trump vetoed it for some reason,” Klain told NBC’s Lester Holt on Feb. 4. “We want to get this back on track. I hope in the next few days, or next week, we may be able to announce some progress on this.”

The US Postal Service had planned to distribute 650 million face coverings for the Trump administration last April, according to internal documents reviewed by CNN in September. A senior administration official told The Washington Post at the time that the plan was scrapped by the White House as some advisers were worried that it could create “concern or panic.”

CNN has reached out to the White House to see if there are any additional details on this after the President’s remarks on Tuesday.

About 65 million Covid-19 vaccine doses administered in the US

People drive through a tent outside Coors Field as they receive a dose of the Pfizer-BioNTech COVID-19 vaccine during a mass vaccination event on February 20 in Denver, Colorado.

More than 65 million doses of Covid-19 vaccine have been administered in the United States, according to data published Tuesday by the US Centers for Disease Control and Prevention.

The CDC reported that 65,032,083 total doses have been administered, about 79% of the 82,114,370 doses delivered.

That’s only about 850,000 more administered doses reported since yesterday, for a seven-day average of about 1.4 million doses per day. 

About 44.5 million people have now received at least one dose of vaccine and about 19.9 million people have been fully vaccinated with both shots, CDC data shows.

Note: Data published by the CDC may be delayed, and doses may not have been given on the day reported.

Ireland's coronavirus lockdown will remain in place until at least April 5

A man walks in Belfast, Ireland, on February 15.

Ireland’s coronavirus lockdown will remain in place until April 5, the government’s press office said in a statement released Tuesday.

A further review of the restrictions will be conducted on April 5, and the government will consider easing limits that currently restrict movement to within three miles of people’s homes, as well as consider easing some restrictions on outdoor activities and meeting other households.

The country will also begin a staggered return to in-school education beginning on March 1, according to the statement. The country’s aim is for all classes to return after the Easter break.

Ireland also plans to resume non-Covid-related health services in the coming weeks and expand the reopening of childcare.

Martin added that the country has made “steady progress” on vaccinations, with more than 350,000 vaccine doses already administered. He said the government plans to give nearly half of people over 18 their first vaccine dose by the end of April, and 82% of adults their first dose by the end of June. 

“We want to protect as many people as possible in the coming months, until we achieve a critical mass of vaccinations,” Martin said. “That is why we will continue to proceed carefully and cautiously, keeping the situation under constant review and being informed at all stages by public health advice.”

It is possible one dose of coronavirus vaccine might be enough for some, NIH director says

Pharmacist Jef Bratberg draws the Moderna Vaccine into syringes at Central Falls High School in Central Falls, Rhode Island, on February 13.

It’s possible a single dose of coronavirus vaccine might be enough for people who have already been infected, but it will take more research to show that, Dr. Francis Collins, director of the National Institutes of Health, wrote in a blog post Tuesday

Collins referenced a recent preprint on a small NIH-funded study, which looked at 109 people who had already received a first dose of the Pfizer or Moderna vaccine and found that for 41 people who had tested positive for SARS-CoV-2 antibodies before their first shot, immune response to the first dose was “equal to, or in some cases better” than the response to the second dose in people without previous infection.

“If other studies support these results, the U.S. Food and Drug Administration might decide to consider whether one dose is enough for people who’ve had a prior COVID-19 infection. Such a policy is already under consideration in France and, if implemented, would help to extend vaccine supply and get more people vaccinated sooner,” wrote Collins. “But any serious consideration of this option will require more data. It will also be up to the expert advisors at FDA and Centers for Disease Control and Prevention to decide.”

Collins said that for now, the most important thing for everyone to do is to continue to follow the three W’s – wear a mask, wash hands and watch distance, “and roll up our sleeves for the vaccine as soon as it’s available to us.”

Scotland to return to "levels" system of Covid restrictions in April

Scottish First Minister Nicola Sturgeon makes a statement on the coronavirus restrictions at the Scottish Parliament on February 23 in Edinburgh, Scotland.

Scotland will begin a phased lifting of its coronavirus lockdown, starting with the lifting of the stay at home order on April 5.

Weeks later the country will move back to a “levels system” of restrictions, First Minister Nicola Sturgeon announced.

Speaking in the Scottish Parliament on Tuesday, Sturgeon said she was confident that the indicative timetable was reasonable and would see the economy start to substantially reopen with further outlines to be published in a Scottish Government document by mid-March. 

The youngest of Scotland’s school pupils returned to classrooms this week. The next phase of school returns will take place on March 15 and will include years four to seven and secondary schools pupils.

At this stage, the outdoor mixing of households rules will allow four people from two households to mix, with these rules changing on April 5 to include six people.

Communal worship will also return, along with essential retail from April 5.

Scotland will then move back to “level three” restrictions on April 26. 

Travel restrictions are likely to remain for the time being, with international travel looking unlikely. 

“One of our biggest risks right now are new variants that start to undermine the vaccine efficacy, that would be a terrible development so that’s why we have to be really careful to guard against importation of new variants, hence the need for travel restrictions.” Sturgeon said. “The more that we accept some restriction on an ability to travel overseas, the greater normality we can get back domestically and get that back quicker than we might otherwise be able to do.”

White House won't say whether Biden would sign a Covid-19 relief bill with an $11 minimum wage

White House press secretary Jen Psaki speaks during a press briefing at the White House on February 23 in Washington, DC.

White House press secretary Jen Psaki would not say whether President Biden would sign a coronavirus relief bill where the minimum wage is increased to $11 an hour as opposed to the $15 an hour that the President proposed.

Asked by CNN’s Kaitlan Collins if Biden would sign a bill where the minimum wage is increased to $11 an hour, something Sen. Joe Manchin is looking at doing via an amendment to the bill, Psaki punted, saying Biden put forward the $15 an hour number because that is what he supports.

Psaki said if the coronavirus relief bill passes the House, which is expected this weekend, “there’ll be an opportunity Sen. Manchin and others to put forward ideas and proposals and we’ll see where that process lands but he proposed the $15 increase for a reason and he stands by it.”

Asked if Biden would consider the lesser minimum wage increase as a possible point of compromise, Psaki said the White House will “see where it goes” after the bill works its way through the Senate reconciliation process.

Manchin said that he would propose the $11 minimum wage amendment if the Senate parliamentarian finds the wage hike within the rules of the budget process that Democrats are employing to advance the covid relief package without Republican support. He would need 51 votes to succeed.

“I would amend it to $11,” he said Monday. “$11 basically works for Americans and, we can do $11 in two years and be in a better position than they’re going to be with $15 in five years.”

New York state has fully vaccinated 1.18 million people, governor says

Elizabeth Griffin, 86, is given her first dose of the Moderna coronavirus vaccine by Anya Harris at Red Hook Neighborhood Senior Center on February 22 in New York City.

New York state has administered more than 2.25 million first doses – 91% of the first doses it received from the federal government, according to the governor of New York.

More than 1.18 million New Yorkers have been fully vaccinated, according to state data. 

Week 10 allocations, which were delayed due to weather, continue to arrive as of Tuesday, Gov. Andrew Cuomo’s office said. 

“Supply from the federal government is increasing steadily every week, but the demand still far outweighs the supply,” Cuomo said in a press release.

He reminded residents that beginning this week, the “largest-yet” vaccination sites in Brooklyn and Queens will each be able to vaccinate 3,000 New Yorkers daily.

States will now receive 14.5 million doses of Covid-19 vaccines per week, White House says

White House Press Secretary Jen Psaki holds a press briefing in the Brady Briefing Room of the White House in Washington, DC, on February 23.

White House press secretary Jen Psaki said Tuesday that states will now receive 14.5 million doses of Covid-19 vaccines per week. 

Psaki said White House Covid-19 coordinator Jeff Zients made the announcement on a call with governors on Tuesday morning. 

“States will now receive 14.5 million doses this week, up from 8.6 million doses per week when the President took office. That’s an increase in vaccine allocations of nearly 70% during the Biden Harris administration,” Psaki said at a White House briefing. 

Earlier today, Pfizer and Moderna — the two companies with Covid-19 vaccines authorized for emergency use in the United States — pledged to make a combined total of 220 million doses available for shipment by the end of March. 

Meanwhile, the company Johnson & Johnson, which has yet to receive an emergency use authorization for its Covid-19 vaccine, has pledged to make 20 million doses available in the same time frame.

Johnson & Johnson says it's ready to ship 4 million doses in US upon emergency use authorization 

Johnson & Johnson COVID-19 vaccine vials are seen at the Klerksdorp Hospital in Klerksdorp, South Africa, on February 18.

Johnson & Johnson, for the first time, put a number on how many initial doses of Covid-19 vaccine it will be able to ship to the US if it is granted emergency use authorization by the US Food and Drug Administration.

The company is prepared to immediately ship nearly 4 million doses, the company’s Dr. Richard Nettles told a House Energy and Commerce Oversight and Investigations panel Tuesday.

More variants discovered in UK and South Africa are now in New York

More variants first identified in the UK, and South Africa, have been discovered in New York State, according to the Governor’s office. 

New York has found 18 more cases of the variant first identified in the UK, bringing the total to 154 known cases. 

The state added that a second case of the variant first identified in South Africa was discovered in Nassau County, on Long island, the state said in a release. 

The state added 6,654 new cases, marking a 4.23% positivity, according to a release from New York Gov. Andrew Cuomo’s office. 

The state adds the qualification that “data, including test results and hospital rates, reported early in the week are often not completely reflective of the current situation due to lower discharges and testing volume over the weekend.”

The 7-day average percent positivity is 3.46%.

Remember: These numbers were released by the state governors office and may not line up with Johns Hopkins University’s tally.

6-year-old girl dies from Covid-19 hours after being diagnosed with a stomach bug

Priscilla and David Morse thought their daughter had a stomach bug, or was perhaps experiencing health symptoms related to her special needs. Less than a day later, six-year-old Gigi died from Covid-19.

The Morse family adopted Gigi from Ukraine when she was three, rescuing her from an orphanage where she was mistreated, at times being tied to a bed and force-fed food. But Gigi would flourish with her new family in Tennessee.

“It was kind of a soul connection kind of thing. She was a very sweet child, but she had a lot of behavioral stuff going on. So she was a little difficult sometimes,” Priscilla explained, adding “but it never bothered me. I dug deep and found patience that I didn’t even know existed, because that’s what she needed. And we just connected.”

In August Gigi developed a peculiar rash, and began vomiting. Now considered telltale signs of Covid-19 in children, at the time the symptoms didn’t raise any flags.

“She was running around the doctor’s office. She was drinking slushies. She had a normal temperature,” her mom explained. “It was just one of those things that you would not associate that with Covid… at the time, we were told she’s got a stomach bug. Take her home. Let her eat some popsicles, get some rest.”

So the Morses did just that, putting Gigi down for a nap before quickly hustling out for refreshments in an effort to keep their daughter hydrated.

“We… went to the store to get popsicles and I came home to two ambulances, fire trucks, police cars in front of my house. And my daughter dead,” Priscilla revealed. 

In July, both David and Priscilla contracted Covid-19, and the family – which also included an 18-year-old and 11-year-old – quarantined accordingly. It was Gigi’s older siblings who found their sister, ultimately contacting 911 and starting CPR.

“They could not have been any more perfect in trying to help their sister. They’re just amazing kids,” said David.

Six months since Gigi’s passing, her family now balances painful feelings of blame, guilt and loss.

“Every single person feels like, ‘what could I have done differently?’ And I don’t know of anyone who could have done anything differently,” Priscilla said.

“At least it happened in a family. She was honored when she passed. She has people who miss her … Gigi, she just took to being in a family. She was everyone’s favorite. She was the light of my life.”

India begins shipping AstraZeneca vaccine doses across Africa

Vials of AstraZeneca-Oxford's Covid-19 vaccine are pictured inside a lab where they are being manufactured at India's Serum Institute in Pune, India, on January 22.

India has begun to ship its AstraZeneca Covid-19 vaccine to countries across Africa through the World Health Organization’s COVAX program, Anurag Srivastava, spokesman for the Ministry of External Affairs announced on Tuesday.

The vaccine doses were processed at the Serum Institute of India.

COVAX is a program co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO. Its aim is to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access for every country in the world.

Last month, India and the African Union announced plans for the Serum Institute to supply 400 million doses to Africa.

India had previously shipped one million doses of the vaccine to South Africa.

“The first batch of Covid-19 vaccines for COVAX rolled out from Serum Institute in Pune, on Tuesday morning,” WHO Southeast Asia said on Twitter.

READ MORE

In stimulus push, Biden calls on Republicans to heed their constituents
Two Floridians attempted to get second doses of the Covid-19 vaccine by dressing as elderly women
Trudeau warns of a dangerous third wave as Canada copes with a vaccine ‘drought’
Food and food packaging highly unlikely to spread Covid-19, experts say
Did you survive Covid? Maybe you can thank your Neanderthal ancestors

READ MORE

In stimulus push, Biden calls on Republicans to heed their constituents
Two Floridians attempted to get second doses of the Covid-19 vaccine by dressing as elderly women
Trudeau warns of a dangerous third wave as Canada copes with a vaccine ‘drought’
Food and food packaging highly unlikely to spread Covid-19, experts say
Did you survive Covid? Maybe you can thank your Neanderthal ancestors